Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis

Por Ma, Wenbo, Tummers, Bart, van Esch, Edith M.G., Goedemans, Renske, Melief, Cornelis J.M., Meyers, Craig, Boer, Judith M., van der Burg, Sjoerd H.
Publicado no Front Immunol (2016)

The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation

Por Tummers, Bart, Goedemans, Renske, Pelascini, Laetitia P. L., Jordanova, Ekaterina S., van Esch, Edith M. G., Meyers, Craig, Melief, Cornelis J. M., Boer, Judith M., van der Burg, Sjoerd H.
Publicado no Nat Commun (2015)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

Por van Poelgeest, Mariette I E, Welters, Marij J P, van Esch, Edith M G, Stynenbosch, Linda F M, Kerpershoek, Gijs, van Persijn van Meerten, Els L, van den Hende, Muriel, Löwik, Margriet J G, Berends-van der Meer, Dorien M A, Fathers, Lorraine M, Valentijn, A Rob P M, Oostendorp, Jaap, Fleuren, Gert Jan, Melief, Cornelis J M, Kenter, Gemma G, van der Burg, Sjoerd H
Publicado em 2013